Hepatitis is inflammation of the liver most commonly caused by any of a group of viruses, but which may also be caused by toxic substances, such as drugs, chemicals, alcohol and environmental toxins.
Hepatitis C virus (HCV) affects about 28,000 people every year and as many as 3.9 million Americans are chronic carriers of the virus. It is estimated that 20% or more of persons with chronic hepatitis C develop cirrhosis, a process that takes 10-20 years.
HCV has the unique ability to cause persistent infection and 70-80% of infected persons become chronic carriers, although most have relatively mild disease with slow progression. The long-term outcome varies significantly for persons with HCV and there is currently no way to determine who will recover or who will develop chronic disease.
Treatment Hepatitis C usually consists of medications, but liver transplant may be appropriate in some cases.
This MediFocus Guide contains an extensive listing of citations and abstracts of recent journal articles that have been published about this condition in trustworthy medical journals. This is the same type of information that is available to physicians and other health care professionals. A partial selection of journal articles that are abstracted in this MediFocus Guide includes:
Hepatitis C infection: opportunity for exposure in many settings. Medicine & Health, Rhode Island. 2000
Renal disease associated with hepatitis C infection after kidney and liver transplantation. Transplantation. 2000
Appropriateness of liver biopsy. Canadian Journal of Gastroenterology. 2000
Risk and management of blood-borne infections in health care workers. Clinical Microbiology Reviews. 2000
Hepatitis C: the silent epidemic. Harvard Mens Health Watch. 2000
Immunogenetics of hepatitis C virus. Journal of Viral Hepatitis. 2000
Transplantation in the patient with hepatitis C. Journal of the American Society of Nephrology. 2000
Liver biopsy in Irish hepatitis C-infected patients with inherited bleeding disorders. British Journal of Haematology. 2000
Hepatitis C, interferon alfa, and depression. Hepatology. 2000
Who's afraid of hepatitis C?. American Journal of Nursing. 2000
MediFocus.com understands that consumers who are facing serious medical issues need access to credible, up-to-date medical information to help them make informed health-care decisions. That's why we've developed the MediFocus Guides...the most advanced and trustworthy patient research guides for over 200 chronic and life-threatening conditions. Each MediFocus Guide includes a detailed overview of the condition including information about diagnosis, treatment options, cutting-edge research, and new developments; excerpts of important journal articles from the current medical literature focusing on standard treatments and treatment options; a directory of leading authors and medical institutions who specialize in the treatment of the condition; and a listing of organizations and support groups where you can obtain additional information about the illness.
MediFocus Guides are the perfect solution for consumers who wish to gain an in-depth understanding of their medical issue and avail themselves of the same type of professional level medical information that is used by physicians and other health-care professionals to help then in the clinical decision making process.
